blonanserin has been researched along with flb 457 in 1 studies
Studies (blonanserin) | Trials (blonanserin) | Recent Studies (post-2010) (blonanserin) | Studies (flb 457) | Trials (flb 457) | Recent Studies (post-2010) (flb 457) |
---|---|---|---|---|---|
121 | 21 | 93 | 104 | 17 | 30 |
Protein | Taxonomy | blonanserin (IC50) | flb 457 (IC50) |
---|---|---|---|
D(2) dopamine receptor | Mus musculus (house mouse) | 0.0012 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, R; Fukuta, H; Honjo, K; Ishihara, K; Kumita, S; Nakamura, H; Okubo, Y; Okumura, M; Tateno, A | 1 |
1 other study(ies) available for blonanserin and flb 457
Article | Year |
---|---|
Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
Topics: Adult; Antipsychotic Agents; Blood-Brain Barrier; Brain; Case-Control Studies; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Piperazines; Piperidines; Positron-Emission Tomography; Pyrrolidines; Raclopride; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Tissue Distribution; Young Adult | 2013 |